The i4KIDS-EUROPE project has advanced pediatric innovation across Europe by establishing a collaborative, action-oriented network that connects stakeholders, identifies unmet needs, and scales impactful solutions. Its achievements represent progress beyond the state of the art, with potential for lasting societal and economic impact. The project delivered the first Europe-wide Paediatric Innovation Situation Report and White Paper, highlighting regulatory fragmentation, underfunding, and poor market access as systemic barriers. These outputs provide a strategic roadmap for EU policymakers and stakeholders. With over 1,000 stakeholders across 34 countries engaged in training programs, mentoring, and Paediatric Innovation Days, the project focused on building human capital, increases innovation adoption, and foster a stronger, more competitive innovation ecosystem. It also work towards Cross-Border Collaboration, bulding a pan-European network, including hospitals, startups, and academia, was established, accelerating knowledge transfer and the adoption of pediatric innovations across borders. Also connections with international ecosystems such as the US. Finally, for long-term Sustainability, the project partners co-developed Sustainability Plan ensures the network’s post-project continuity, including ongoing funding strategies and collaboration frameworks.
Wider Socioeconomic Impact
By boosting access to pediatric innovation in underserved regions, the project addresses health inequities and supports EU goals of social inclusion. However, challenges still remain. First, a financially secured and sustainable network is essential to maintain the activities started in the framework of the project. Second, resources to continue the ongoing research and demonstration are essential to tackle the complex needs of paediatric healthcare, with further projects required to prove the potential, effectiveness and scalability of these innovations. To this regard, more funding and research and development is needed, with continued investment, awareness and lobbying for improved regulatory adaptation, and innovative market access strategies in Europe and global reach.
